Safe and Effective Combination of Donor-Derived, Allogeneic CD19/CD22-CAR T Cells with Myeloablative Graft-Engineered Allo-HCT for High-Risk B-ALL by Muffly, Lori, Ananth, Snegha, Danley, Lindsay, Wagner, Caroline, Kordek, Diana, DeNoble, Kimi, Fraser, Ayesha, Egeler, Emily, Molina, Alfonso, Ehlinger, Zachary, Desai, Moksha, Daghagh, Hossein, Tunuguntla, Ramya, Brown, Annie K., Ibañez, Raquel, Kramer, Anne Marijn, Good, Zinaida, Arai, Sally, Johnston, Laura, Lowsky, Robert, Rezvani, Andrew R., Shizuru, Judith, Mikkilineni, Lekha, Shiraz, Parveen, Sidana, Surbhi, Weng, Wen-Kai, Kennedy, Vanessa E., Bharadwaj, Sushma, Dahiya, Saurabh, Frank, Matthew J., Meyer, Everett H., Negrin, Robert S., Feldman, Steven A., Mackall, Crystal L., Sahaf, Bita, Miklos, David B., Smith, Melody

Get full text